Related Experiment Video
Updated: Feb 10, 2026
Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity
Published on: June 25, 2015
[Experimental study on effect of recombined decoction on mumps virus]
Zhengyun Zhang1, Laizhi Yang, Qinzhong Liu
1Department of Stomatology, Shanxi Hospital, Xi'an Jiaotong University, Xi'an 710068, China.
Objective:
To evaluate possible inactivating effect of recombined decoction in on mumps virus.
Methods:
By adopting tissue cell culturing technology, a group of viruses including the mumps virus, herpes simplex virus (type I, II), rubella virus, cytomegalovirus (CMV), herpes zoster virus, influenza virus, parainfluenza virus, adeno viruses, respiratory syneytial virus (RSV) were cultured. The cells infected with the viruses were treated with the decoction.
Results:
The decoction showed remarkable inhibitory and killing effects on the mumps virus while had no obvious inhibitory and killing effects on host's cells, herpes simplex virus (type I, II), rubella virus, cytomegalovirus (CMV), herpes zoster virus, influenza virus, parainfluenza virus, adeno viruses, respiratory syneytial virus (RSV).
Conclusions:
The decoction had obvious inhibitory and killing effects on mumps virus during single layer cells culture.
